Literature DB >> 313325

Improved sensitivity of the BTPABA pancreatic function test in animals with meals of raw egg white.

A R Imondi, R L Wolgemuth.   

Abstract

An indirect exocrine pancreatic function test (PFT) which measures the ability of a test to hydrolyze a chymotrypsin-labile peptide (N-benzoyl-L-tyrosyl-PABA), was carried out in rats and swine with simulated partial exocrine pancreatic insufficiency. When spray-dried egg white (SDEW), which contains an inhibitor of chymotrypsin, was administered as a test meal with the PFT, the degree of pancreatic insufficiency was more pronounced. The results suggest that SDEW or raw egg while may be useful as a test meal to be given in conjunction with the PFT in humans in order to accentuate moderate degrees of pancreatic insufficiency and improve the sensitivity of this indirect test of pancreatic function.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313325     DOI: 10.1007/bf01308432

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  Inhibition of human chymotrypsin by dried egg white.

Authors:  A R Imondi; J L Ferguson; R L Wolgemuth
Journal:  Am J Dig Dis       Date:  1973-12

2.  Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency.

Authors:  E P DiMagno; V L Go; W H Summerskill
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

3.  Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by the synthetic peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid.

Authors:  S Nousia-Arvanitakis; C Arvanitakis; N Desai; N J Greenberger
Journal:  J Pediatr       Date:  1978-05       Impact factor: 4.406

4.  Study on the exocrine pancreatic function by the oral administration of N-benzoyl-L-tyrosyl-para-aminobenzoic acid.

Authors:  K Kato; S Izumiyama; M Sakakura; A Hirayama; K Ishii
Journal:  Gastroenterol Jpn       Date:  1977

5.  Diagnosis of exocrine pancreatic disease by synthetic peptide.

Authors:  R A Rittgers; A E Feinerman; M S Loewenstein; N Zamcheck
Journal:  Lancet       Date:  1977-04-30       Impact factor: 79.321

6.  Diagnosis of pancreatic disease by a synthetic peptide. A new test of exocrine pancreatic function.

Authors:  C Arvanitakis; N J Greenberger
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

7.  Letter: Diagnosis of exocrine pancreatic disease by synthetic peptide.

Authors:  J G Salway; R B Payne
Journal:  Lancet       Date:  1976-07-10       Impact factor: 79.321

8.  [Methodological and first clinical investigations using a new pancreatic function test].

Authors:  W Bornschein; F L Goldmann; M Otte
Journal:  Clin Chim Acta       Date:  1976-02-16       Impact factor: 3.786

9.  Oral administration of a chymotrypsin-labile peptide--a new test of exocrine pancreatic function in man (PFT).

Authors:  K Gyr; G A Stalder; I Schiffmann; C Fehr; D Vonderschmitt; H Fahrlaender
Journal:  Gut       Date:  1976-01       Impact factor: 23.059

10.  Synthetic peptides in the diagnosis of exocrine pancreatic insufficiency in animals.

Authors:  A R Imondi; R P Stradley; R Wolgemuth
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

View more
  2 in total

1.  Prospective comparison of three non-invasive tests for pancreatic disease.

Authors:  J Braganza
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-01

Review 2.  Exocrine pancreatic function tests.

Authors:  P G Lankisch
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.